Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychosis and positron tomography.

M V Seeman1, P Seeman

  • 1Department of Psychiatry, University of Toronto, Mount Sinai Hospital, Ontario.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patients.

Scientific reports·2021
Same author

Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.

European journal of neurology·2020
Same author

Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2.

Clinical genetics·2018
Same author

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses.

Acta psychiatrica Scandinavica·2017
Same author

Charcot-Marie-Tooth 1A: Heterozygous T118M Mutation over a CMT1A Duplication Has No Influence on the Phenotype.

Annals of the New York Academy of Sciences·2017
Same author

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.

Translational psychiatry·2016

Positron emission tomography (PET) offers new ways to study psychosis. PET scans show neuroleptic drugs control schizophrenia symptoms by blocking D2 dopamine receptors, not D1.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Radiology

Background:

  • Schizophrenia and other psychotic states lack objective biological markers.
  • Neurotransmitter receptor imaging is crucial for understanding brain function in psychiatric disorders.

Purpose of the Study:

  • To explore the utility of positron emission tomography (PET) in identifying objective biological indices for psychotic states, specifically schizophrenia.
  • To investigate the role of dopamine receptors in the efficacy of neuroleptic treatment for schizophrenia.

Main Methods:

  • Utilizing positron emission tomography (PET) technology to measure brain neurotransmitter receptor densities.
  • Comparing PET findings in schizophrenia patients undergoing neuroleptic treatment with healthy controls.

Related Experiment Videos

Main Results:

  • PET imaging successfully measured brain neurotransmitter receptor densities.
  • Schizophrenia symptoms like hallucinations and delusions were linked to the blockage of D2 dopamine receptors by neuroleptics.
  • D1 dopamine receptors were not found to be involved in symptom control.

Conclusions:

  • PET is a highly sensitive tool for studying brain neurotransmitter systems in psychiatric conditions.
  • D2 dopamine receptor blockade is confirmed as the mechanism of action for neuroleptics in managing schizophrenia symptoms.
  • Further research is needed to resolve technical challenges in PET imaging for elevated D2 receptor studies.